Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • First-time generic approved for Truvada®

    by
    • Optum Workers' Comp
    | Jun 29, 2017
    Tag Icon
    Generics, FDA
    The U.S. Food and Drug Administration (FDA) recently approved Teva’s AB-rated generic for Gilead’s Truvada® (emtricitabine/tenofovir disoproxil fumarate) 200 mg/300 mg oral tablet. This is the first time a generic has been approved for this medication. Truvada is a combination antiretroviral medication indicated for use in combination with other antiretroviral medications for the treatment of human immunodeficiency virus type-1 (HIV-1) infection in adults and pediatric patients weighing at least 17 kg (approximately 37.5 pounds), and in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk.


  • Teva introduces generic Skelaxin®

    by
    • Optum Workers' Comp
    | Jun 22, 2017
    Tag Icon
    Generics
    Teva Pharmaceuticals announced it will be manufacturing a generic version of Skelaxin® (metaxalone) tablets. Skelaxin is a skeletal muscle relaxant used to relieve discomfort associated with acute, painful musculoskeletal conditions as an adjunctive therapy. Metaxalone is currently available in 400 mg and 800 mg tablets; however, Teva is only advertising the launch of 800 mg tablets. This new generic adds to a list of other previously released generic metaxalone tablets.


  • Update to Voluntary recall of Eliquis® (apixaban) 5 mg tablets

    by
    • Optum Workers' Comp
    | Jun 22, 2017
    Tag Icon
    Medication Recall, FDA
    UPDATE: On June 10, one lot of Eliquis was recalled and designated as a consumer-level recall. On June 17, this recall was changed to a retail/dispensing level only recall. The recall is currently underway at the pharmacy level. As a reminder, patients should not stop taking Eliquis without consulting with their doctor. For more information on this update, click here.


  • Texas releases informal draft rule to close compounded loophole

    by
    • Optum Workers' Comp
    | Jun 20, 2017
    Tag Icon
    Workers' Compensation, Formularies, Compounded Medications
    The Texas Division of Workers’ Compensation (DWC) recently released an informal draft rule amending the closed formulary definition in Rule 134.500. The amended definition would exclude any compounded medication from the closed formulary. Medications excluded from the Texas Closed Formulary can only be prescribed following a prior authorization process including documentation of medical necessity. Previously, only compounded medications with an “N” ingredient, as identified in the Official Disability Guidelines (ODG) Appendix A, were excluded from the closed formulary.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.